DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 130 filers reported holding DIPLOMAT PHARMACY INC in Q3 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $704,000 | +316.6% | 175,929 | +409.4% | 0.00% | – |
| Q3 2019 | $169,000 | -1.2% | 34,538 | +22.7% | 0.00% | – |
| Q2 2019 | $171,000 | -48.6% | 28,158 | +63.9% | 0.00% | – |
| Q3 2018 | $333,000 | -26.7% | 17,181 | -3.4% | 0.00% | -100.0% |
| Q2 2018 | $454,000 | -17.0% | 17,781 | -34.5% | 0.00% | 0.0% |
| Q1 2018 | $547,000 | +3.4% | 27,144 | +43.6% | 0.00% | 0.0% |
| Q3 2016 | $529,000 | -22.9% | 18,900 | -3.6% | 0.00% | 0.0% |
| Q2 2016 | $686,000 | +175.5% | 19,600 | +115.4% | 0.00% | – |
| Q1 2016 | $249,000 | -25.0% | 9,100 | -6.2% | 0.00% | -100.0% |
| Q4 2015 | $332,000 | +19.0% | 9,700 | 0.0% | 0.00% | – |
| Q3 2015 | $279,000 | -37.7% | 9,700 | -3.0% | 0.00% | -100.0% |
| Q2 2015 | $448,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |